Cannabis is on fire this year. 2018 has lead to an explosion in the Cannabis markets with companies like Medmen listing on the exchanges and creating Cannabis Unicorns.
This week Tilray, a global leader in medical cannabis research, cultivation, processing, and distribution has listed on the Nasdaq exchange (TLRY) and has opened the U.S. to a true Cannabis company. The IPO is off to a good start and Tilray has risen to great heights after its opening on Thursday. The initial projections of $14-$16 have been passed and the stock is sitting around the $30 mark.
Tilray has been able to transport Cannabis to multiple countries and has a very robust board and executive pool. Let’s see how the market takes the company as the initial draw settles and the stock cools.